Indian wind turbine maker Suzlon Energy Ltd (BOM:532667) returned to positive EBITDA of INR 3.16 billion (USD 50m/EUR 45m) in fiscal 2014/15, ended in March, but its net loss widened.
The company said on Friday its performance in the past fiscal year has been affected by working capital challenges, which have now been addressed. Suzlon recently completed the EUR-1-billion (USD 1.1bn) sale of German wind turbine maker Senvion SE and it also welcomed Dilip Shanghvi, founder of Sun Pharmaceutical Industries, as a shareholder.
The table below contains Suzlon’s profit and revenue for the past year and quarter.
|Results in INR
|Net loss after minority interest
||negative 1.4 billion
“In FY16, our key priorities are to ramp- up volumes, improve profitability, strengthen customer centric approach and enhance our market share,” commented chairman Tulsi Tanti. The company’s order book has reached 1.12 GW, which translates into INR 68.86 billion.
(INR 100 = USD 1.567/EUR 1.428)
Choose your newsletter by Renewables Now. Join for free!